1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
Repligen Corp. XNAS: RGEN

Repligen Corp. Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vacc...

Read More
123.55 1.38 (1.13%)
32.31% Fall from 52W High
262.4K
XNAS Volume

XNAS 29 Aug, 2025 1:58 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Repligen Corp. is on 04 Sep 2025 for the purpose of The Wells Fargo Healthcare Conference See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
15.3 / 100
Momentum Score
Technically Neutral
47.1 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
180
1Yr Price target upside is 45%
18 analysts

7

S

11

W

1

O

2

T

SWOT Analysis

Repligen Corp. Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..